Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F V Lewis

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Drug Metabolism Letters|July 16, 2009
Electronic and structural aspects of p450-mediated drug metabolismDavid F V Lewis, Yuko Ito, Brian G Lake
Drug Discovery Today|June 9, 2004
Compound lipophilicity for substrate binding to human P450s in drug metabolismDavid F V Lewis, Miriam N Jacobs, Maurice Dickins
Current Drug Metabolism|August 22, 2006
Investigating human P450s involved in drug metabolism via homology with high-resolution P450 crystal structures of the CYP2C subfamilyDavid F V Lewis, Yuko Ito, Peter S Goldfarb
Teratogenesis, Carcinogenesis, and Mutagenesis|March 5, 2003
A quantitative structure-activity relationship (QSAR) study of mutagenicity in several series of organic chemicals likely to be activated by cytochrome P450 enzymesDavid F V Lewis, Costas Ioannides, Dennis V Parke
Toxicology in Vitro : an International Journal Published in Association with BIBRA|September 15, 2005
Metabolism of coumarin by human P450s: a molecular modelling studyDavid F V Lewis, Yuko Ito, Brian G Lake
Journal of Biochemical and Molecular Toxicology|March 5, 2003
A quantitative structure-activity relationship analysis on a series of alkyl benzenes metabolized by human cytochrome p450 2E1David F V Lewis, Craig Sams, George D Loizou
Journal of Enzyme Inhibition and Medicinal Chemistry|June 23, 2006
Quantitative structure-activity relationships (QSars) in CYP3A4 inhibitors: the importance of lipophilic character and hydrogen bondingDavid F V Lewis, Brian G Lake, Maurice Dickins
Current Medicinal Chemistry|October 5, 2006
Structural modelling of the human drug-metabolizing cytochromes P450David F V Lewis, Yuko Ito, Peter S Goldfarb
Drug Metabolism and Drug Interactions|October 29, 2004
Substrates of human cytochromes P450 from families CYP1 and CYP2: analysis of enzyme selectivity and metabolismDavid F V Lewis, Brian G Lake, Maurice Dickins
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 28, 2004
Quantitative structure-activity relationships within a homologous series of 7-alkoxyresorufins exhibiting activity towards CYP1A and CYP2B enzymes: molecular modelling studies on key members of the resorufin series with CYP2C5-derived models of human CYP1A1, CYP1A2, CYP2B6 and CYP3A4David F V Lewis, Brian G Lake, M Dickins
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Drug Metabolism Letters|July 16, 2009
Electronic and structural aspects of p450-mediated drug metabolismDavid F V Lewis, Yuko Ito, Brian G Lake
Drug Discovery Today|June 9, 2004
Compound lipophilicity for substrate binding to human P450s in drug metabolismDavid F V Lewis, Miriam N Jacobs, Maurice Dickins
Current Drug Metabolism|August 22, 2006
Investigating human P450s involved in drug metabolism via homology with high-resolution P450 crystal structures of the CYP2C subfamilyDavid F V Lewis, Yuko Ito, Peter S Goldfarb
Teratogenesis, Carcinogenesis, and Mutagenesis|March 5, 2003
A quantitative structure-activity relationship (QSAR) study of mutagenicity in several series of organic chemicals likely to be activated by cytochrome P450 enzymesDavid F V Lewis, Costas Ioannides, Dennis V Parke
Toxicology in Vitro : an International Journal Published in Association with BIBRA|September 15, 2005
Metabolism of coumarin by human P450s: a molecular modelling studyDavid F V Lewis, Yuko Ito, Brian G Lake
Journal of Biochemical and Molecular Toxicology|March 5, 2003
A quantitative structure-activity relationship analysis on a series of alkyl benzenes metabolized by human cytochrome p450 2E1David F V Lewis, Craig Sams, George D Loizou
Journal of Enzyme Inhibition and Medicinal Chemistry|June 23, 2006
Quantitative structure-activity relationships (QSars) in CYP3A4 inhibitors: the importance of lipophilic character and hydrogen bondingDavid F V Lewis, Brian G Lake, Maurice Dickins
Current Medicinal Chemistry|October 5, 2006
Structural modelling of the human drug-metabolizing cytochromes P450David F V Lewis, Yuko Ito, Peter S Goldfarb
Drug Metabolism and Drug Interactions|October 29, 2004
Substrates of human cytochromes P450 from families CYP1 and CYP2: analysis of enzyme selectivity and metabolismDavid F V Lewis, Brian G Lake, Maurice Dickins
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 28, 2004
Quantitative structure-activity relationships within a homologous series of 7-alkoxyresorufins exhibiting activity towards CYP1A and CYP2B enzymes: molecular modelling studies on key members of the resorufin series with CYP2C5-derived models of human CYP1A1, CYP1A2, CYP2B6 and CYP3A4David F V Lewis, Brian G Lake, M Dickins
Pageof 6